Veena S Rao, Jesse Wrenn, Jeffrey M Testani, Kevin Damman, Jozine M Ter Maaten, Hasan K Siddiqi, Sean P Collins, Ryan Walsh, Kelly Schlendorf, Karen F Miller, Henry Ooi, JoAnn Lindenfeld, Juan B Ivey-Miranda, Jin H Han, Brian Bales, Lynne W Stevenson, Zachary L Cox, Alan B Storrow
Journal: Heart failure reviews 2024;29(6):1161-1173
PMID: 39128947
Diuresis to achieve decongestion is a central aim of therapy in patients hospitalized for acute decompensated heart failure (ADHF). While multiple approaches have been tried to achieve adequate decongestion rapidly while minimizing adverse effects, no single diuretic strategy has shown superiority, and there is a paucity of data and guidelines to utilize in making these decisions. Observational cohort studies have shown associations between urine sodium excretion and outcomes after hospitalization for ADHF. Urine chemistries (urine sodium ± urine creatinine) may guide diuretic titration during ADHF, and multiple randomized clinical trials have been designed to compare a strategy of urine chemistry-guided diuresis to usual care. This review will summarize current literature for diuretic monitoring and titration strategies, outline evidence gaps, and describe the recently completed and ongoing clinical trials to address these gaps in patients with ADHF with a particular focus on the utility of urine sodium-guided strategies.
© 2024. The Author(s).
Full Text Sources:
Medical:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.